News Focus
News Focus
Followers 62
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: Investor2014 post# 135389

Wednesday, 12/27/2017 3:54:22 PM

Wednesday, December 27, 2017 3:54:22 PM

Post# of 518982
Yes but you have compared SOC where they have already figured out the right dose and response. So the present patient group should only be compared with the whole group of SOC in the same phase with weak doses as well.
Meaning 10 patients 30 mg drug A compared to 10 patients 30 mg drug B.

Also you are comparing SOC first 6 months with A273 after 2 years.
2x bad comparing dose SOC vs A283 and duration its working SOC vs A283

There is no comparing. There has not been ANY drug with that dose doing what A273 is doing after so long still!



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News